首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   12381篇
  免费   1637篇
  国内免费   337篇
耳鼻咽喉   430篇
儿科学   272篇
妇产科学   123篇
基础医学   2230篇
口腔科学   57篇
临床医学   1396篇
内科学   1185篇
皮肤病学   74篇
神经病学   328篇
特种医学   463篇
外国民族医学   16篇
外科学   1822篇
综合类   2204篇
预防医学   433篇
眼科学   203篇
药学   705篇
  11篇
中国医学   212篇
肿瘤学   2191篇
  2024年   38篇
  2023年   243篇
  2022年   376篇
  2021年   636篇
  2020年   658篇
  2019年   582篇
  2018年   508篇
  2017年   572篇
  2016年   672篇
  2015年   613篇
  2014年   877篇
  2013年   795篇
  2012年   686篇
  2011年   724篇
  2010年   552篇
  2009年   466篇
  2008年   520篇
  2007年   507篇
  2006年   466篇
  2005年   397篇
  2004年   341篇
  2003年   310篇
  2002年   271篇
  2001年   253篇
  2000年   233篇
  1999年   189篇
  1998年   180篇
  1997年   146篇
  1996年   151篇
  1995年   154篇
  1994年   124篇
  1993年   126篇
  1992年   105篇
  1991年   97篇
  1990年   79篇
  1989年   73篇
  1988年   67篇
  1987年   59篇
  1986年   71篇
  1985年   72篇
  1984年   47篇
  1983年   29篇
  1982年   46篇
  1981年   50篇
  1980年   42篇
  1979年   21篇
  1978年   30篇
  1977年   33篇
  1976年   16篇
  1975年   19篇
排序方式: 共有10000条查询结果,搜索用时 23 毫秒
31.
Department of Biology, Izhevsk Medical Institute. (Presented by Academician of the Academy of Medical Sciences of the USSR D. S. Sarkisov.) Translated from Byulleten' Éksperimental'noi Biologii i Meditsiny, Vol. 107, No. 3, pp. 353–356, March, 1989.  相似文献   
32.
原发性甲状腺功能亢进症合并甲状腺癌18例分析   总被引:1,自引:0,他引:1  
目的:探讨原发性甲状腺功能亢进症(甲亢)合并甲状腺癌(甲癌)的诊断和治疗。方法:回顾分析1990年1月于2000年1月手术治疗18例甲亢合并甲癌患者的临床资料,结果:微小癌占83%(15/18)。术前彩超检查15例,14例发现可疑结节;13例行癌侧叶全切除和对侧叶次全切除术,5例行双侧叶次全切除术,其中3例同时行颈淋巴结清扫术,1例二次行颈淋巴结清扫术。随访16例,平均随访7年,1例死于癌肺转移,余者仍存活,结论:术前常规彩超检查发现可疑结节有助于术中冰冻切片病理检查,手术治疗应兼顾甲亢和甲癌。  相似文献   
33.
目的:探讨降低喉返神经损伤的方法。方法:2005年9月-2007年1月共有375例甲状腺手术患者,对其喉返神经损伤进行分析。结果:375例病人中有5例喉返神经损伤,其中甲状腺腺瘤3例,桥本甲状腺炎1例,甲状腺癌1例,损伤后立即行喉镜检查示声带处于外展位。给予营养神经治疗,15 d-3个月后完全恢复,喉镜检查示声带正常。结论:喉返神经损伤可以预防,关键是术者应熟悉喉返神经的解剖结构和变异,熟悉其与周围组织及血管的关系,要有手术区域的组织结构特别是喉返神经走行的“立体影像”。  相似文献   
34.
Delayed graft function (DGF) in cadaver kidney transplants is a common problem and is often due to acute tubular necrosis (ATN). DGF in transplants may have a deleterious effect on long-term graft survival. Since thyroid hormone has been shown to hasten recovery from ATN in experimental models, we designed a trial to determine if a defined course of triiodothyronine (T3) would improve the short- or long-term outcome of patients with DGF in cadaveric transplants. A prospective, randomized, placebo controlled, double blind trial of T3 was carried out in patients with DGF in cadaveric renal transplants. End-points were percentage requiring dialysis, percentage recovering function, time to recovery and length of hospital stay. Long-term outcomes were percentage grafts functioning at 1 year and mean serum creatinine at 1 year. Forty-four patients were randomized to receive either T3 or placebo. Three patients were dropped from each group when early biopsies disclosed that DGF was due to rejection. The groups were well matched by age, cold ischemia time of the graft, and percentage reactivity to a random panel of antigens. Baseline thyroid function studies, including T3, reverse T3 (rT3), and thyroid stimulating hormone (TSH) levels, were similar between the two groups and typical of 'euthyroid-sick syndrome'. T3 had no effect on percentage requiring dialysis, time to recovery, percentage recovering function, or length of stay. At 1 year follow-up, graft function was similar in both groups and significantly lower than that seen in patients with good initial function. Thyroid hormone, given early in the course of DGF in cadaver kidney recipients, had no effect on the course of DGF. Long-term graft function is impaired in patients who experience post-transplant DGF compared to those who have good initial function.  相似文献   
35.
张钧  李鸣  李平 《西南国防医药》2007,17(4):420-422
目的:探讨甲状腺全切除术在治疗分化性甲状腺癌中的临床应用价值。方法:采用我院1988年1月~2001年5月甲状腺全切除术或甲状腺侧叶切除加峡部切除术治疗分化性甲状腺癌125例,对其手术并发症发生、局部复发、转移情况及术后5年生存率进行回顾性对比分析。结果:甲状腺全切除术术后并发症发生率高于甲状腺侧叶切除加峡部切除术组;局部复发、转移率低于侧叶切除加峡部切除术组;5年生存率两组无显著性差异。结论:甲状腺全切除术是治疗甲状腺癌有效的手术方式,但应掌握手术指征,改进、提高手术技术,减少并发症。  相似文献   
36.
Background Insular thyroid carcinoma was described as a tumor with aggressive behavior, and patients usually present themselves with an advanced tumor stage. Whether the insular component is an independent factor for poor prognosis remains unclear. Therefore, in the present study, we compared the survival of patients with advanced insular, follicular, and papillary thyroid cancer. Materials and methods The clinical behavior of tumors in three groups of patients with T4 thyroid carcinoma—8 patients with insular, 11 patients with follicular, and 21 patients with papillary thyroid carcinomas—was compared. Disease-free survival and disease-specific death were analyzed statistically. Cox regression analysis was used to evaluate the influence of histotype and other prognostic factors. Results At 3 years, survival was 37.5% (mean 26 months) among patients with insular thyroid carcinoma, 80% (mean 59 months) among those with follicular, and 89% (mean 126 months) among those with papillary thyroid carcinomas (p = 0.007). Disease-free survival in patients without initial distant metastasis was worst in patients with insular thyroid carcinoma (20%) compared to those with follicular (75%) and those with papillary thyroid carcinomas (71%). Conclusion Patients with advanced insular thyroid carcinoma have a poorer outcome in comparison to patients with similar advanced stage who have follicular or papillary thyroid carcinoma.  相似文献   
37.
Management of upper gastrointestinal bleeding because of erosion of vessels by esophageal cancer may be challenging. We present herein the angiographic images of a 49-year-old patient who was admitted with massive bleeding from a tumor-eroded inferior thyroid artery. Attempts to control the bleeding by means of flexible endoscopy and insertion of a Sengstaken–Blakemore tube had failed. The diagnosis was impressively demonstrated by multislice computed tomography with intravenous contrast in the arterial phase and multiplanar reconstructions (computed tomography angiography) and by digital subtraction angiography. The bleeding was successfully treated with superselective catheterization and coiling of the eroded vessel.  相似文献   
38.
女性腹膜原发癌临床病理分析   总被引:1,自引:1,他引:0  
刘琦  石群立  吴波  孟奎  马恒辉  孙桂勤  陆珍凤 《医学研究生学报》2004,17(7):616-619,623,F004
目的:分析12例女性腹膜原发癌(FPCP)(10例浆液癌、1例黏液癌、1例子宫内膜样癌)的临床病理及免疫组化特征,以引起临床医师重视。方法:复习我院1992至2002年间12例FPCP患者临床资料及病理切片,收集随访资料,记录大体标本所见,调出全部蜡块重新切片,并行PAS染色及细胞角蛋白(CK)7、CK20、ER、PR、牛血清清蛋白100(S-100)、卵巢癌抗原(CA)125、癌胚抗原(CEA)、CD15免疫组化染色。结果:12例患者年龄在32—67(平均48.75)岁,10/11例患者血CA125明显增高。组化及免疫组化染色示阳性者:PAS为7/11,CK7为10/11,CK20为10/11,CD15为11/11,S-100为8/11,CA125为6/11,CEA为6/11,ER为4/11,PR为2/11。黏液性腹膜癌预后极差,其余类型与卵巢原发性上皮癌相似。结论:女性FPCP被认为起源于中肾旁管(Muller管),组织学上与同类型的卵巢癌一致,在排除卵巢原发癌的基础上可作出诊断,免疫组化有助于区分女性FPCP、腹膜间皮瘤和卵巢原发癌。本病预后差。  相似文献   
39.
40.
 We describe a rare case of papillary carcinoma with extensive proliferation of stromal cells. The stromal cells were immunocytochemically positive for vimentin, α-smooth muscle actin and desmin, but negative for cytokeratin, epithelial membrane antigen, S-100, thyroglobulin and CD34. These results and the ultrastructure of the stromal cells, which exhibited the characteristics of both fibroblasts and smooth muscle cells, indicated an origin from myofibroblasts. We conclude that myofibroblastic proliferation may contribute to the stromal response in the slow growth of the papillary carcinoma. Received: 29 August 1996 / 26 May 1997  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号